Alternative donor peripheral blood stem cell transplantation for the treatment of high-risk refractory and/or relapsed childhood acute leukemia: a randomized trial

BACKGROUND: The high-risk refractory and/or relapsed (R/R) childhood acute leukemia prognosis is poor, and allogeneic stem cell transplantation (allo-HSCT) is the most prudent treatment modality. However, there are limited matched sibling donors (MSDs), and alternative donors (ADs) are the main sour...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Binglei, Zhou, Jian, Yu, Fengkuan, Lv, Tianxin, Fang, Baijun, Fan, Dandan, Ji, Zhenyu, Song, Yongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137207/
https://www.ncbi.nlm.nih.gov/pubmed/32280563
http://dx.doi.org/10.1186/s40164-020-00162-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137207/
https://www.ncbi.nlm.nih.gov/pubmed/32280563
http://dx.doi.org/10.1186/s40164-020-00162-6

Ejemplares similares